SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000448
Filing Date
2021-07-12
Accepted
2021-07-12 17:00:33
Documents
12
Period of Report
2021-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K flxn-20210709.htm   iXBRL 8-K 41534
  Complete submission text file 0000950170-21-000448.txt   158523

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flxn-20210709.xsd EX-101.SCH 2462
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flxn-20210709_lab.xml EX-101.LAB 13496
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flxn-20210709_pre.xml EX-101.PRE 10001
5 EXTRACTED XBRL INSTANCE DOCUMENT flxn-20210709_htm.xml XML 4710
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 211086069
SIC: 2834 Pharmaceutical Preparations